We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Adults with type 2 diabetes improved time in range after ...

ANN ARBOR, Mich.--(BUSINESS WIRE)--Newly published results from a clinical study of the Diabetes Insulin Guidance System (DIGS™), under development by Hygieia, Inc., demonstrate DIGS’ potential to ...

Looking to the European market, digital therapeutics company Amalgam Rx has scored an E.U. CE Mark for its insulin titration algorithm, called iSage Rx, and its white-label variants. This comes more ...

AmalgamRx, a newly unstealthed company founded by WellDoc founders Ryan Sysko and Dr. Suzanne Clough, has received FDA clearance for iSage, an insulin titration algorithm. “One of the big challenges ...

MILPITAS, Calif.--(BUSINESS WIRE)--Bigfoot Biomedical (Bigfoot), a leader in developing intelligent connected injection support systems, today announced the acquisition of a reinforcement learning ...

Glycemic control outcomes were similar between patients with type 2 diabetes who received insulin titration on the basis of an AI-assisted system vs a physician. Real-time artificial intelligence (AI) ...

Those who titrated their own insulin experienced more rapid glycemic control and lower risks for macrosomia than when clinicians led titration. Both approaches resulted in similar mean fasting glucose ...

A custom artificial intelligence (AI) app for insulin management advice helped patients with type 2 diabetes gain rapid glycemic control, a small randomized clinical trial found. In titrating basal ...

Diabetes, affecting millions worldwide, poses a significant challenge to the healthcare system due to the complexity of therapy and difficulty to adequately control the disease. Particularly, patients ...

Artificial intelligence (AI) can match physician insulin dosing, maintaining target blood sugar levels in patients with type 2 diabetes. A study showed an AI-based insulin decision support system's ...

It is estimated that approximately 25%–30% of hospitalized adults have diabetes. Numerous studies have demonstrated the benefits of technological advances such as continuous glucose monitoring (CGM) ...